Abstract:BACKGROUND:Acidic extracellular pH is a major feature of tumor tissue. Acid-sensing ion channels (ASICs) represent an H(+)-gated subgroup of the degenerin/epithelial Na(+) channel family and are activated by acidic microenvironment. Little is known about the expression and clinical significance of ASICs in solid tumors. The purpose of this study was to examine the expression of ASIC1 in human clear cell renal cell carcinoma (CCRCC) and to determine if the expression of ASIC1 is associated with clinicopathological features.METHODS:The expression of ASIC1 in CCRCC tissues at the mRNA and protein levels was determined by real-time quantitative polymerase chain reaction and Western blot analysis, respectively. A tissue microarray was used to assess the expression of ASIC1 protein in tumor tissue and matched adjacent normal tissues from 75 patients with CCRCC.RESULTS:ASIC1 expression was detected in normal renal and CCRCC samples. The expressions of ASIC1 protein and mRNA were significantly decreased in the CCRCC tissues compared with matched normal renal tissues (P<0.05). The staining density measurement showed that the expression of ASIC1 was significantly decreased in stage I (P=0.037), stage II (P=0.026), and stage III (P=0.026), grades I-II CCRCC (P=0.004), and CCRCC from male patients (P=0.00002). However, no significant difference was observed for ASIC1 expression between CCRCC and normal tissue in patients with stage IV CCRCC (P=0.236), patients with grades III-IV CCRCC (P=0.314), and female patients (P=0.095). Spearman correlations demonstrated that ASIC1 expression did not correlate to tumor stage (correlation coefficient [CC =0.168], P=0.149) and the age of patients (CC -0.147, P=0.688) but showed a positive correlation to higher tumor grades (CC =0.270, P=0.018).CONCLUSION:ASIC1 is downregulated in CCRCC. ASIC1 expression may be potentially used as a novel biomarker and even a CCRCC therapeutic target. Further efforts will be made to clarify the mechanism of ASIC1 in occurrence, progression, and metastasis of CCRCC.

Acid-sensing ion channel 1: potential therapeutic target for tumor

Acid-sensing Ion Channel 1a Modulation of Apoptosis in Acidosis-Related Diseases: Implications for Therapeutic Intervention

Involvement of Acid-Sensing Ion Channel 1α in Hepatic Carcinoma Cell Migration and Invasion

Proton-sensing ion channels, GPCRs and calcium signaling regulated by them: implications for cancer

Pathology and Physiology of Acid‑sensitive Ion Channels in the Digestive System (Review)

ASIC1 and ASIC3 Contribute to Acidity-Induced EMT of Pancreatic Cancer Through Activating Ca 2+ /rhoa Pathway

ASIC1a contributes to the epithelial–mesenchymal transformation of breast cancer by activating the Ca2+/β‐catenin pathway

Acid-sensing Ion Channels: Potential Therapeutic Targets for Neurologic Diseases.

Alteration of ASIC1 Expression in Clear Cell Renal Cell Carcinoma.

ASIC1 promotes migration and invasion of hepatocellular carcinoma via the PRKACA/AP-1 signaling pathway

Acid-sensing ion channel 1a mediates acid-induced increases in intracellular calcium in rat articular chondrocytes

pH regulators and their inhibitors in tumor microenvironment

The Acidic Tumor Microenvironment: a Target for Smart Cancer Nano-Theranostics

Acid-sensing Ion Channels: Trafficking and Pathophysiology.

Involvement of Acid-Sensing Ion Channel 1a in Gastric Carcinoma Cell Migration and Invasion

ASIC1α up-regulates MMP-2/9 expression to enhance mobility and proliferation of liver cancer cells via the PI3K/AKT/mTOR pathway

Acid-sensing ion channels: a novel therapeutic target for pain and anxiety.

Dynamic Regulation of Acid-Sensing Ion Channels by Extracellular and Intracellular Modulators

Severely polarized extracellular acidity around tumour cells

Function Study of Acid-Sensing Ion Channels in Non-Neuronal Tissues

ASIC3-activated key enzymes of de novo lipid synthesis supports lactate-driven EMT and the metastasis of colorectal cancer cells